Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory W Stagliano

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neuroscience Letters|September 3, 2003
kappa-Opioid withdrawal in PlanariaRobert B Raffa, Gregory W Stagliano, Sumiyo Umeda
Brain Research|July 28, 2004
Cocaine and kappa-opioid withdrawal in Planaria blocked by D-, but not L-, glucoseSumiyo Umeda, Gregory W Stagliano, Robert B Raffa
Brain Research|August 18, 2006
Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in PlanariaRobert B Raffa, Gregory W Stagliano, Ronald J Tallarida
European Journal of Pharmacology|December 5, 2006
Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planariansRobert B Raffa, Gregory W Stagliano, Ronald J Tallarida
European Journal of Pharmacology|January 20, 2004
Protonation effect on drug affinityRobert B Raffa, Gregory W Stagliano, Shawn D Spencer
Journal of Pharmacological and Toxicological Methods|December 15, 2004
A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in PlanariaSumiyo Umeda, Gregory W Stagliano, Michael R Borenstein, et al.
Journal of Pharmacological and Toxicological Methods|December 8, 2005
Measurement of glutamate and aspartate in PlanariaScott M Rawls, Teresa Gomez, Gregory W Stagliano, et al.
Brain Research|January 8, 2008
The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'Robert B Raffa, Gregory W Stagliano, Geoffrey Ross, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neuroscience Letters|September 3, 2003
kappa-Opioid withdrawal in PlanariaRobert B Raffa, Gregory W Stagliano, Sumiyo Umeda
Brain Research|July 28, 2004
Cocaine and kappa-opioid withdrawal in Planaria blocked by D-, but not L-, glucoseSumiyo Umeda, Gregory W Stagliano, Robert B Raffa
Brain Research|August 18, 2006
Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in PlanariaRobert B Raffa, Gregory W Stagliano, Ronald J Tallarida
European Journal of Pharmacology|December 5, 2006
Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planariansRobert B Raffa, Gregory W Stagliano, Ronald J Tallarida
European Journal of Pharmacology|January 20, 2004
Protonation effect on drug affinityRobert B Raffa, Gregory W Stagliano, Shawn D Spencer
Journal of Pharmacological and Toxicological Methods|December 15, 2004
A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in PlanariaSumiyo Umeda, Gregory W Stagliano, Michael R Borenstein, et al.
Journal of Pharmacological and Toxicological Methods|December 8, 2005
Measurement of glutamate and aspartate in PlanariaScott M Rawls, Teresa Gomez, Gregory W Stagliano, et al.
Brain Research|January 8, 2008
The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'Robert B Raffa, Gregory W Stagliano, Geoffrey Ross, et al.
Pageof 1